{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:42:24Z","timestamp":1786732944324,"version":"build-2736575974"},"reference-count":0,"publisher":"Archives of Endocrinology and Metabolism","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["A&amp;EM"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Objective: Pediatric Graves\u2019 disease (PGD) is a rare autoimmune disorder. Predictors of remission after antithyroid drug (ATD)\ntherapy have been described, but their applicability in pediatric populations remains inconsistent. This study aimed to identify\nclinical and biochemical factors associated with remission in PGD. Subjects and methods: Retrospective observational study of\nchildren diagnosed with Graves\u2019 disease at a tertiary hospital in Portugal (2001\u20132021), all initially treated with ATD. Demographic,\nclinical, and biochemical data at diagnosis, as well as treatment characteristics, were analyzed. The primary outcome\nwas \u201cIn Remission\u201d. Secondary outcomes included \u201cRemission Experienced\u201d and \u201cDisease Not Active \u22651 Month\u201d. Comparative\nanalyses, logistic regression, and receiver operating characteristic (ROC) curves were applied. Results: Among 45,000 pediatric\npatients, 36 had PGD (prevalence 0.08%). Median age at diagnosis was 13.7 years; 81% were female, and 78% were pubertal.\nMethimazole was prescribed in 81%. Mean initial treatment duration (ITD) was 35 months, and 47% of patients underwent\ndefinitive therapy. At data collection, 18% of patients were in remission. Longer ITD (&gt;24 months) was associated with remission;\nthe optimal cutoff ITD was 51 months. Smaller thyroid volume and TRAb levels at diagnosis correlated with \u201cDisease Not\nActive \u22651 Month\u201d. Thyroid volume \u22652.5-fold the upper limit of normal (ULN) and TRAb \u22657.055-fold the ULN reduced the likelihood\nof disease inactivity. Conclusion: Prolonged ATD therapy, smaller thyroid volume, and lower TRAb levels at diagnosis were\nassociated with favorable outcomes in PGD. The optimal ITD (\u226551 months) supports extended ATD therapy. Larger multicenter\nstudies are warranted to confirm these results.<\/jats:p>","DOI":"10.20945\/2359-4292-2026-0089","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:24:15Z","timestamp":1786731855000},"page":"1-13","source":"Crossref","is-referenced-by-count":0,"title":["Predictive factors for remission in pediatric Graves\u2019 disease treated with antithyroid drugs: a retrospective study"],"prefix":"10.20945","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8175-8426","authenticated-orcid":false,"given":"Ana Jo\u00e3o","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1086-4506","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6468-125X","authenticated-orcid":false,"given":"Rita Aldeia","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-9431","authenticated-orcid":false,"given":"Mariana","family":"Portela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-1320","authenticated-orcid":false,"given":"Sofia","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9612-0589","authenticated-orcid":false,"given":"Olinda","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6277-6037","authenticated-orcid":false,"given":"Ana","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1728-9387","authenticated-orcid":false,"given":"Maria Miguel","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","published-online":{"date-parts":[[2026]]},"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"https:\/\/www.aem-sbem.com\/article\/predictive-factors-for-remission-in-pediatric-graves-disease-treated-with-antithyroid-drugs-a-retrospective-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:24:17Z","timestamp":1786731857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/predictive-factors-for-remission-in-pediatric-graves-disease-treated-with-antithyroid-drugs-a-retrospective-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]},"published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2026-0089","relation":{},"ISSN":["2359-3997"],"issn-type":[{"value":"2359-3997","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}